EUVIMEDEUVIMED entdecken
Scoping Review

Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review

Yongqiang Yang, Jiayuan Qin iD, Ya Hu iD, Junna Wang, Yu Feng iD, Zhiyong Zong iD

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiaf635 ↗

Kurz gefasst

Scoping Review in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Yongqiang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Carbapenems, Carbapenem-Resistant Enterobacteriaceae. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is classified by the World Health Organization as a top-priority pathogen due to its extensive prevalence and dissemination, antimicrobial resistance, and high mortality rates. ST11 CRKP is the most prevalent type in parts of Asia and South America. The success and dissemination of ST11 CRKP can be partly attributed to several key evolutionary events, including the acquisition of the KPC-2 plasmid plus altered outer membrane proteins OmpK35 and OmpK36 that confer carbapenem resistance, the subsequent capsule switching that led to the emergence of the KL64 capsule type, and the further acquisition of virulence plasmids commonly associated with the hypervirulent ST23 lineage. In this review, we summarize the current research advances of these key events, discuss existing knowledge gaps, and propose future directions to understand why ST11 CRKP has emerged as such a dominant and clinically significant clone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsCarbapenemsCarbapenem-Resistant EnterobacteriaceaeAnti-Bacterial AgentsHumansPlasmidsBacterial ProteinsVirulencebeta-LactamasesPorinsAsiaSouth America

Stichwörter der Autor:innen

Klebsiella pneumoniaeKL64ST11carbapenem resistancevirulence plasmid

Substanzen

CarbapenemsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesPorins

Autor:innen und Institutionen

  • Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Pathogen Research, West China Hospital, Sichuan University, Chengdu, China.
  • Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Jiayuan Qin, Ya Hu, Yu Feng, Zhiyong Zong

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Yang, Y., Qin, J., Hu, Y., Wang, J., Feng, Y., & Zong, Z. (2026). Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf635

Vancouver

Yang Y, Qin J, Hu Y, Wang J, Feng Y, Zong Z. Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf635

BibTeX
@article{Yang2026,
  author = {Yang, Yongqiang and Qin, Jiayuan and Hu, Ya and Wang, Junna and Feng, Yu and Zong, Zhiyong},
  title = {Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiaf635}
}
Kostenlos starten →